Portola Pharmaceuticals Inc (PTLA) Inventory Turnover Ratio, from first quarter 2020 to first quarter 2019, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Portola Pharmaceuticals inc   (NASDAQ: PTLA)
 

Portola Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Portola Pharmaceuticals Inc 's inventory turnover ratio, the ratio that measures Portola Pharmaceuticals Inc 's ability to manage its supply chain, sequentially decreased to 14.35 in the first quarter 2020, but it does not raise any concerns as Portola Pharmaceuticals Inc continue to execute well, and the inventory turnover ratio remains above the average. Portola Pharmaceuticals Inc 's average inventory processing period in the Mar 31 2020 quarter, has increased to 25 days, from 22 days, in the Dec 31 2019 quarter.

Within Healthcare sector 34 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2020, to 323, from total ranking in the fourth quarter 2019 at 324.

PTLA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Portola Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PTLA Inventory Turnover Ratio (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Inventory Growth 33.83 % -47.91 % -61.51 % -78.16 % -17.73 %
Y / Y Cost of Sales Growth -39.58 % 138.31 % -37.47 % 374.43 % 2027.98 %
Inventory Turnover Ratio (TTM) 14.35 16.63 7.54 6.33 4.19
PTLA's Total Ranking # 323 # 324 # 324 # 324 # 324
Average inventory processing period 25 22 48 58 87
Seq. Inventory Growth -12.8 % 73.99 % 52.36 % -42.1 % -66.06 %
Seq. Cost of Sales Growth -85.38 % 1001.08 % -46.22 % -30.2 % -42.34 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 35
Overall Market # 323

Inventory Turnover Ratio Statistics
High Average Low
16.63 7.62 1.35
(Dec 31 2019)   (Sep 30 2018)



PTLA Company Profile >> Back to PTLA Efficiency Comparisons >> Compare PTLA Inventory Turnover Ratio to its Competitors

Financial Statements
Portola Pharmaceuticals Inc 's Inventories $ 4 Millions Visit PTLA's Balance sheet
Portola Pharmaceuticals Inc 's Cost of Revenues TTM $ 42 Millions Visit PTLA's Income Statement
What are PTLA's Sales? Visit PTLA's Sales by Segment

Other Inventory Turnover Ratios
Portola Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PTLA's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PTLA's Competitors
Inventory Turnover Ratio for PTLA's Suppliers
Inventory Turnover Ratio for PTLA's Customers

You may also want to know
PTLA's Sales Growth Rates PTLA's Pe Price to earnings ratio PTLA's Receivables Turnover Ratio PTLA's Stock Quote
PTLA's Net Income Growth Rates PTLA's Ps Price to Sales ratio PTLA's Sales per Employee PTLA's Asset Turnover Ratio
PTLA's Net Margin PTLA's Pb Price to Book ratio PTLA's Financial Strength Ratios PTLA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2020 Inventories at quarter ending Mar 31 2020
U s Stem Cell Inc   31.36 $ 0.831  Millions$ 0  Millions
Scientific Industries Inc   31.10 $ 88.273  Millions$ 3  Millions
Biora Therapeutics Inc   26.57 $ 77.680  Millions$ 3  Millions
Heartbeam Inc   26.09 $ 168.155  Millions$ 6  Millions
Tivity Health Inc   24.11 $ 736.876  Millions$ 31  Millions
Surgery Partners Inc   23.55 $ 1,081.500  Millions$ 46  Millions
Collegium Pharmaceutical Inc   22.98 $ 254.649  Millions$ 11  Millions
Option Care Health Inc   22.69 $ 2,223.537  Millions$ 98  Millions
Innovage Holding Corp   22.55 $ 45.634  Millions$ 2  Millions
Rennova Health Inc   19.52 $ 13.125  Millions$ 1  Millions
Fortress Biotech Inc   18.00 $ 14.844  Millions$ 1  Millions
Precipio inc   17.73 $ 3.324  Millions$ 0  Millions
Avalo Therapeutics Inc   17.41 $ 4.602  Millions$ 0  Millions
Health right Discoveries Inc   17.30 $ 0.373  Millions$ 0  Millions
Vaso Corporation  17.16 $ 33.533  Millions$ 2  Millions
Vanda Pharmaceuticals Inc   17.09 $ 19.375  Millions$ 1  Millions
Biotricity Inc   15.89 $ 0.725  Millions$ 0  Millions
Irhythm Holdings Inc   15.63 $ 56.818  Millions$ 4  Millions
Smiledirectclub Inc   15.58 $ 272.832  Millions$ 18  Millions
Biocept Inc   15.20 $ 11.325  Millions$ 1  Millions
Clearday Inc   15.17 $ 2.579  Millions$ 0  Millions
Rockwell Medical inc   15.14 $ 58.658  Millions$ 4  Millions
Catalyst Pharmaceuticals Inc   15.01 $ 18.910  Millions$ 1  Millions
Portola Pharmaceuticals inc   14.35 $ 41.548  Millions$ 3  Millions
Star Equity Holdings Inc   13.96 $ 96.555  Millions$ 7  Millions
Healthlynked Corp  13.55 $ 1.218  Millions$ 0  Millions
Castle Biosciences Inc   12.22 $ 11.694  Millions$ 1  Millions
Incyte Corporation  12.12 $ 118.980  Millions$ 10  Millions
Natera Inc   12.01 $ 163.016  Millions$ 14  Millions
Puma Biotechnology Inc   11.80 $ 37.906  Millions$ 3  Millions

Date modified: 2026-08-29T17:19:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.